Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of Third-Party Administration (TPA), data management, COVID-19 related diagnostics and vaccinations, 340B contracted pharmacy services, prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Company profile
Ticker
RXMD
Exchange
Website
CEO
Shital Parikh Mars
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
PROGRESSIVE TRAINING, INC.
SEC CIK
Corporate docs
Subsidiaries
Pharmco, LLC • Touchpoint RX, LLC • Family Physicians RX, Inc. • ClearMetrX, Inc. ...
IRS number
320186005
RXMD stock data
Latest filings (excl ownership)
425
Business combination disclosure
17 Apr 24
8-K
Transaction Expected to Provide Revenue Synergies and Significant Initial Annual Operating Cost Reductions
17 Apr 24
8-K
Results Driven by 17% Increase in Pharmacy Prescription Revenue and Over 136% Growth in 340B Contract Services Revenue
11 Apr 24
10-K
2023 FY
Annual report
10 Apr 24
8-K
Results of Operations and Financial Condition
14 Nov 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
340B Contract Revenue Drives Quarterly Top-Line Growth as Operating Income Reaches Record Levels
14 Aug 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
8-K
Departure of Directors or Certain Officers
21 Jul 23
8-K
Progressive Care Inc. Announces First Quarter 2023 Financial Results and Record Quarterly Revenues of $11.4 Million
12 May 23
Transcripts
RXMD
Earnings call transcript
2022 Q2
12 Aug 22
RXMD
Earnings call transcript
2022 Q1
18 May 22
RXMD
Earnings call transcript
2021 Q4
28 Mar 22
RXMD
Earnings call transcript
2021 Q2
17 Aug 21
RXMD
Earnings call transcript
2020 Q2
17 Aug 20
RXMD
Earnings call transcript
2019 Q4
1 Apr 20
RXMD
Earnings call transcript
2019 Q3
15 Nov 19
RXMD
Earnings call transcript
2019 Q2
15 Aug 19
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 7.01 mm | 7.01 mm | 7.01 mm | 7.01 mm | 7.01 mm | 7.01 mm |
Cash burn (monthly) | 112.40 k | 27.72 k | 458.25 k | 70.10 k | 86.61 k | 36.62 k |
Cash used (since last report) | 745.58 k | 183.85 k | 3.04 mm | 464.97 k | 574.48 k | 242.88 k |
Cash remaining | 6.27 mm | 6.83 mm | 3.98 mm | 6.55 mm | 6.44 mm | 6.77 mm |
Runway (months of cash) | 55.8 | 246.5 | 8.7 | 93.4 | 74.4 | 184.9 |
Institutional ownership, Q4 2022
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 44.78 mm |
Total shares | 1.13 bn |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
NXPL NextPlat | 1.13 bn | $44.78 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Oct 23 | Pedro Rodriguez | Common Stock, par value $0.0001 per share | Grant | Acquire A | No | No | 4.5 | 11,111 | 50.00 k | 31,667 |
21 Jul 23 | Jervis Hough | Common Stock, par value $0.0001 per share | Grant | Acquire A | No | No | 5.37 | 9,311 | 50.00 k | 42,957 |
1 Jul 23 | Charles M. Fernandez | Common Stock | Acquire X | Yes | No | 2.2 | 230,000 | 506.00 k | 2,172,855 | |
1 Jul 23 | Charles M. Fernandez | Common Stock | Sell | Dispose S | Yes | No | 4.45 | 168,386 | 749.32 k | 1,942,855 |
1 Jul 23 | Charles M. Fernandez | Common Stock | Acquire X | Yes | No | 2.2 | 340,599 | 749.32 k | 2,111,241 | |
1 Jul 23 | Charles M. Fernandez | Common Stock | Sell | Dispose S | Yes | No | 4.45 | 224,944 | 1.00 mm | 1,770,642 |
1 Jul 23 | Charles M. Fernandez | Common Stock | Acquire X | Yes | No | 2.2 | 455,000 | 1.00 mm | 1,995,586 | |
1 Jul 23 | Charles M. Fernandez | Common Stock | Sell | Dispose S | Yes | No | 4.45 | 93,932 | 418.00 k | 1,540,586 |
1 Jul 23 | Charles M. Fernandez | Common Stock | Acquire X | Yes | No | 2.2 | 190,000 | 418.00 k | 1,634,518 | |
1 Jul 23 | Charles M. Fernandez | Common Stock | Sell | Dispose S | Yes | No | 4.45 | 112,838 | 502.13 k | 1,444,518 |
Press releases
NEXTPLAT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of NextPlat Corp - NXPL
17 Apr 24
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IP, NXPL, NS, RXMD
17 Apr 24
Kuehn Law Encourages NS, NXPL, IP, and RXMD Investors to Contact Law Firm
17 Apr 24
RXMD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Progressive Care Inc. Is Fair to Shareholders
15 Apr 24
NextPlat Announces Proposed Business Combination with Progressive Care Inc.
12 Apr 24